home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

88.85 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

72 73 Next >

A Look Into BioNTech Inc's Price Over Earnings ↗

May 08, 2023

Via Benzinga

Woodstock For Capitalists ↗

May 08, 2023

Good Morning Everyone! Regional bank PacWest is up 34% in pre-market after being up 81% Friday. They slashed their dividend to conserve capital. With a 19% short interest on the stock, there is...

Via Benzinga

WHO Ends Global Emergency Status for COVID-19, Virgin Galactic Plans To Launch Space Tourism In Q2, Berkshire Hathaway Has No Intentions To Take Control Of Occidental Petroleum: Today's Top Stories ↗

May 08, 2023

Benzinga

Via Benzinga

BioNTech Stock Jumps As Covid Vaccine Sales, Profits Beat Expectations ↗

May 08, 2023

The launch of an updated booster could increase demand.

Via Investor's Business Daily

Earnings Preview For BioNTech ↗

May 05, 2023

Via Benzinga

How To Attend BioNTech Q1 2023 Earnings Conference Call ↗

April 27, 2023

Via Benzinga

Buy This Pharma Powerhouse With A 4% Yield ↗

April 21, 2023

Imagine a company whose stock hit an all-time in December 2021 after soaring 50% that year. And that company’s sales doubled in the two years leading up to 2022. And its operating profits quadrupled.

Via Talk Markets

P/E Ratio Insights for BioNTech ↗

April 20, 2023

Via Benzinga

Despite Continuous Dip In Covid-19 Vaccine Sales, BioNTech Manages To Post Q1 Profit, Reaffirms Guidance ↗

May 08, 2023

BioNTech SE (NASDAQ: BNTX) reported Q1 FY23 revenues of €1.28 billion, down from €6.37 billion a year ago, mainly due to lower commercial revenues from the supply and sales of the

Via Benzinga

WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns ↗

May 08, 2023

The World Health Organization ended the global emergency

Via Benzinga

US Stocks Set For Mixed Start This Week On Inflation, Debt Ceiling Worries — But Analyst Sees A 'Turning Point' ↗

May 08, 2023

Caution returned to Wall Street as indicated by the index futures, which traded narrowly mixed early Monday.

Via Benzinga

BioNTech Announces First Quarter 2023 Financial Results and Corporate Update

May 08, 2023

From BioNTech SE

Via GlobeNewswire

Overview Of Value Stocks In The Healthcare Sector ↗

April 17, 2023

Via Benzinga

What 12 Analyst Ratings Have To Say About BioNTech ↗

April 10, 2023

Via Benzinga

The 7 Best Bargain Stocks to Buy for May 2023 ↗

May 04, 2023

With inflation crimping everyone’s wallet, these best bargain stocks to buy can make your dollars stretch significantly.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

May 04, 2023

Via Benzinga

First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories ↗

May 01, 2023

Benzinga

Via Benzinga

European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals ↗

May 01, 2023

The European Union bloc is reportedly negotiating an amended deal with Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) for around 70 million COVID-19 vaccine doses, despite the European public...

Via Benzinga

A Look Into BioNTech Inc's Price Over Earnings ↗

April 03, 2023

Via Benzinga

Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks? ↗

April 28, 2023

Experts fear a change in how Medicare buys drugs could slam biotech and pharma companies.

Via Investor's Business Daily

BioNTech to Report First Quarter 2023 Financial Results and Operational Update on May 8, 2023

April 24, 2023

From BioNTech SE

Via GlobeNewswire

Novavax Plummets On Downgrade: Is It The Covid Engine That Couldn't? ↗

April 20, 2023

The company is facing a litigation headwind and continued competition.

Via Investor's Business Daily

7 Low-PE Ratio Blue-Chip Stocks Offering Both Quality and Value ↗

April 19, 2023

Make your dollars go as far as possible (and relatively safely) with these low-PE ratio blue-chip stocks to buy.

Via InvestorPlace

FDA Gives Green Signal To Second Omicron-Adapted Booster Shots For People At High Risk From Covid ↗

April 18, 2023

Via Benzinga

US Court Favors Moderna In COVID-19 Vaccine Patent Infringement Case With Arbutus Biopharma ↗

April 12, 2023

Via Benzinga

Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments ↗

April 11, 2023

The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a...

Via Benzinga

Week In Review: Suzhou Duality Out-Licenses Two ADCs To BioNTech In $1.7 Billion Deal ↗

April 08, 2023

Duality Biologics out-licensed global rights (ex-China) for two ADC candidates to BioNTech, Pfizer’s partner, for one of the two original COVID-19 vaccines in a deal worth $170 million upfront and up...

Via Talk Markets

Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots ↗

April 04, 2023

Via Benzinga

Arbutus Biopharma and Genevant Sciences File Patent Infringement Lawsuit Against Pfizer/BioNTech

April 04, 2023

From Arbutus Biopharma Corporation

Via GlobeNewswire

BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors

April 03, 2023

From BioNTech SE

Via GlobeNewswire

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com